Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Up to 20 subjects will be treated. Subjects will receive two (2) bilateral Ultherapy™ or Sham
treatments of the axilla. The study hypothesis is that subjects who receive Ultherapy™
treatment will have a greater reduction in axillary sweating compared to subjects receiving
Sham treatments. Follow-up visits will occur at 7 and 14 days following treatment #1, and at
7, 14, 30, 60 and 90 days following treatment #2. At each follow-up visit, assessments will
be completed to compare the amount of axillary sweating compared to baseline.